The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
Open accessAbstract
Given the current SARS-CoV-2 (COVID-19) pandemic, the availability of reliable information for clinicians and patients is paramount. There have been a number of reports stating that non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids may exacerbate symptoms in COVID-19 patients. Therefore, this review aimed to collate information available in published articles to identify any evidence behind these claims with the aim of advising clinicians on how best to treat patients. This review found no published evidence for or against the use of NSAIDs in COVID-19 patients. Meanwhile, there appeared to be some evidence that corticosteroids may be beneficial if utilised in the early acute phase of infection, however, conflicting evidence from the World Health Organisation surrounding corticosteroid use in certain viral infections means this evidence is not conclusive. Given the current availability of literature, caution should be exercised until further evidence emerges surrounding the use of NSAIDs and corticosteroids in COVID-19 patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Lu, H. (2020) · BioScience Trends · doi:10.5582/bst.2020.01020 · Cited by 1,133
Fu, Y., Cheng, Y., & Wu, Y. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00207-4 · Cited by 788
Russell, B., Moss, C., George, G., Santaolalla, A., Cope, A., Papa, S., & Van Hemelrijck, M. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1022 · Cited by 439
Self-citationZhao, Z. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05320-0 · Cited by 407
Indomethacin Has a Potent Antiviral Activity against Sars Coronavirus
Amici, C., Caro, A. D., Ciucci, A., Chiappa, L., Castilletti, C., Martella, V., Decaro, N., Buonavoglia, C., Capobianchi, M. R., & Santoro, M. G. (2006) · Antiviral Therapy · doi:10.1177/135965350601100803 · Cited by 203
The management of coronavirus infections with particular reference to SARS
Wong, S. S. Y., & Yuen, K. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn243 · Cited by 101
Severe acute respiratory syndrome: clinical and laboratory manifestations.
Lam, C. W. K., Chan, M. H. M., & Wong, C. K. (2004) · PubMed Central · Cited by 91
Zhang, X., Alekseev, K. P., Jung, K., Vlasova, A. N., Hadya, N., & Saif, L. J. (2008) · Journal of Virology · doi:10.1128/jvi.02190-07 · Cited by 56
Cited by
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
Bindu, S., Mazumder, S., & Bandyopadhyay, U. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114147 · Cited by 1,920
Lechien, J. R., Chiesa‐Estomba, C. M., Place, S., Van Laethem, Y., Cabaraux, P., Mat, Q., Huet, K., Plzak, J., Horoi, M., Hans, S., et al. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13089 · Cited by 800
Brown, E., Gray, R., Lo Monaco, S., O'Donoghue, B., Nelson, B., Thompson, A., Francey, S., & McGorry, P. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.005 · Cited by 366
Tutunchi, H., Naeini, F., Ostadrahimi, A., & Hosseinzadeh‐Attar, M. J. (2020) · Phytotherapy Research · doi:10.1002/ptr.6781 · Cited by 255
Does Ibuprofen Worsen COVID-19?
Moore, N., Carleton, B., Blin, P., Bosco-Levy, P., & Droz, C. (2020) · Drug Safety · doi:10.1007/s40264-020-00953-0 · Cited by 78
Metadata
- Authors
- Russell, B., Moss, C., Rigg, A., & Van Hemelrijck, M.
- Venue
- ecancermedicalscience
- Publisher
- Ecancer Global Foundation
- Published
- 2020-03-30
- Volume
- 14
- Pages
- 1023-1023
- ISSN
- 1754-6605 (ISSN-L)
- OpenAlex
- W3013336676
- Cited by
- 286
- References
- 12
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? https://app.cochat.ai/papers/10.3332/ecancer.2020.1023
- The paper
- Russell, B., Moss, C., Rigg, A., & Van Hemelrijck, M. (2020). COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? ecancermedicalscience. https://doi.org/10.3332/ecancer.2020.1023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.